Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor

NCT07707882 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Tenosynovial Giant Cell Tumor, Diffuse

Interventions

DRUG: Pimicotinib
PROCEDURE: Tumor resection surgery

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine